1Pama C J, Kim J, Riel RU, et al. , Cardioproteetive effects of erythropoietin in the reperfused ischemic heart: A potential role for cardiac fibroblasts. J B iol Chem. , 2004,279 (20) : 20655 - 20662.
2Maiese K, Li F, Chong ZZ. , New avenues of exploration for erythropoietin. JAMA. 2005, 293(1) : 90 -95.
3Fishbane S,Recombinant human erythropoietin: has treatment reached its full potential? Semin Dial,2006,19 ( 1 ) : 1 - 4.
4Erbayraktar S, Grasso G, Sfacteria A, et al. , Asialoerythropoietin is a nonerythropoietic cytokine with broad neuroprotective activity in vivo. Proc Natl Acad Sci , 2003, 100:6741 -6746.
5Wang X, Zhu C, Wang X, et al. , The nonerythropoietie asialoerythropoietin protects against neonatal hypoxia - isehemia as potently as erythropoietin. J Neuroehem,2004,91 (4.) : 900 -010.
6Grasso G, Sfacteria A, Erbayraktar S, et al. , Amelioration of spinal cord compressive injury by pharmacological preconditioning with erythropoietin and a nonerythropoietic erythropoietin derivative. J Neurosurg Spine,2006,4(4) :310-318.
7Fiordaliso F, Chimenti S, Staszewsky L,et al. , A nonerythropoietic derivative of erythropoietin protects the myocardium from ischemia - reperfusion injury. Proc Natl Acad Sci, 2005,102(6) : 2046 -2051.
8Brines M, Grasso G, Fiordaliso F, et al. , Erythropoietin mediates tissue protection through an erythropoietin and common beta - sbunit heteroreceptor. Proc Natl Acad Sci , 2004,101 (410) : 14907 -14912.
9Savino C, Pedotti R, Baggi F, et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis .J Neuroimmunol,2006,172(1-2):27-37.
10Montero M, Poulsen FR, Noraberg J, et al. Comparison of neuroproteetive effects of erythropoietin (Epo) and earbamylerythropoietin (CEpo) against ischemia-like oxygen-glucose deprivation (OGD) and NMDA excitotoxicity in mouse hippocampal slice cultures. Exp Neurol, 2007,204 ( 1 ) : 106 - 117.
